CUMBERLAND PHARMACEUTICALS INC·4

Mar 27, 5:50 PM ET

Anthony Todd M. 4

4 · CUMBERLAND PHARMACEUTICALS INC · Filed Mar 27, 2023

Insider Transaction Report

Form 4
Period: 2023-03-24
Anthony Todd M.
Vice Pres Organizational Dev
Transactions
  • Award

    Options (right to buy)

    2023-03-24+3,00012,000 total
    Exercise: $1.97From: 2027-03-24Exp: 2033-03-24Common Stock (3,000 underlying)

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION